v3.26.1
Collaboration, License and Option Agreements - Summary of Contract Assets and Liabilities (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2026
USD ($)
Deferred revenue  
Deferred revenue as of beginning of period $ 60,658
Additions 6,000
Collaboration and license revenue recognized (31,340)
Deferred revenue as of end of period 35,318
Collaboration and Stock Purchase Agreement | AbbVie  
Deferred revenue  
Deferred revenue as of beginning of period 34,007
Additions 6,000
Collaboration and license revenue recognized (20,726)
Deferred revenue as of end of period 19,281
License and Stock Purchase Agreement | Gilead  
Deferred revenue  
Deferred revenue as of beginning of period 26,651
Collaboration and license revenue recognized (10,614)
Deferred revenue as of end of period $ 16,037